This is our world. Welcome to our website
The main achievements of the first phase were:
- Development of a classification of users of medical devices.
- A survey of industrial methods in the medical device sector.
- Demonstration for the first time that the ‘experience curve’ (similar to cost-volume curve) applies to healthcare products.
- Methodological development to articulate the value of safety in medical devices.
- Progress on the transferability of cost-effectiveness results from country to country.
- Methodological development in supply-side theory, including pricing strategy.
- Pathways analysis of the impact of telemedicine and point of care technologies.
- A preliminary set of tools for technology communities in industry and the NHS.
- Built a team that communicates across disciplinary and university boundaries.
- Development of staff:
- One former Research Fellow now has a Chair in China.
- Another ran a team at the National Co-ordinating Centre for Health Technology Assessment.
- Studies with commercial partners that have made a difference to industry and have yielded important insights into what decision-making support is needed and
- £600k of industrial cash and nearly £900k of additional grant and RDA funding.